Recent Posts
- Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.
- Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025
- Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
- Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024
- Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30